Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain Pathology

• Publication date

  2016-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bpa.12335PMID 26512942PMCID PMC8029302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species

  2015cited by this paper
• Tau Protein Provides DNA with Thermodynamic and Structural Features which are Similar to those Found in Histone-DNA Complex

  2014cited by this paper
• Tau promotes neurodegeneration through global chromatin relaxation

  2014cited by this paper
• Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: A feasibility study

  2014cited by this paper
• Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

  2014cited by this paper
• Structural basis of the translational elongation cycle.

  2013cited by this paper
• Discriminative Analysis of Mild Alzheimer’s Disease and Normal Aging Using Volume of Hippocampal Subfields and Hippocampal Mean Diffusivity

  2013cited by this paper
• Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons

  2013cited by this paper
• Ribosomal proteins: Structure, function, and evolution

  2012cited by this paper
• The elongation, termination, and recycling phases of translation in eukaryotes.

  2012cited by this paper
• Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.

  2012cited by this paper
• The many roles of the eukaryotic elongation factor 1 complex

  2012cited by this paper
• Interaction of nucleolin with ribosomal RNA genes and its role in RNA polymerase I transcription

  2012cited by this paper
• Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?

  2012cited by this paper
• tRNA mimicry in translation termination and beyond

  2011cited by this paper
• Epigenetic Silencing of Nucleolar rRNA Genes in Alzheimer's Disease

  2011cited by this paper
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

  2011cited by this paper
• Nucleolar stress is an early response to myocardial damage involving nucleolar proteins nucleostemin and nucleophosmin

  2011cited by this paper
• Nucleolin

  2011cited by this paper
• NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling

  2010cited by this paper
• Nuclear Tau, a Key Player in Neuronal DNA Protection*

  2010cited by this paper
• New evidences on Tau-DNA interactions and relevance to neurodegeneration.

  2010cited by this paper
• The mechanism of eukaryotic translation initiation and principles of its regulation

  2010cited by this paper
• Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.

  2010cited by this paper
• NPM3, a member of the nucleophosmin/nucleoplasmin family, enhances activator-dependent transcription.

  2010cited by this paper
• The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.

  2009cited by this paper
• A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.

  2009cited by this paper
• Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

  2009cited by this paper
• Ribosomal Proteins: Role in Ribosomal Functions

  2009cited by this paper
• Chromatin: linking structure and function in the nucleolus

  2009cited by this paper
• Binding to the Minor Groove of the Double-Strand, Tau Protein Prevents DNA from Damage by Peroxidation

  2008cited by this paper
• The post-transcriptional steps of eukaryotic ribosome biogenesis

  2008cited by this paper
• Nucleolus, ribosomes, and cancer.

  2008cited by this paper
• Histone deacetylase 6 interacts with the microtubule‐associated protein tau

  2008cited by this paper
• Identification and characterization of nucleoplasmin 3 as a histone‐binding protein in embryonic stem cells

  2008cited by this paper
• New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones

  2007cited by this paper
• Nucleolin is a histone chaperone with FACT‐like activity and assists remodeling of nucleosomes

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• Oxidative Damage to RNA in Neurodegenerative Diseases

  2006cited by this paper
• Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

  2006cited by this paper
• Alzheimer's disease-related alterations in synaptic density: Neocortex and hippocampus

  2006cited by this paper
• Chromatin Decondensation and Nuclear Reprogramming by Nucleoplasmin

  2006influential reference
• Quantification of oxidized RNAs in Alzheimer's disease.

  2006cited by this paper
• Nucleophosmin Is Essential for Ribosomal Protein L5 Nuclear Export

  2006cited by this paper
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

  2006cited by this paper
• Decreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease

  2006cited by this paper
• Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization

  2006influential reference
• Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

  2006cited by this paper
• Eukaryotic ribosomal proteins lacking a eubacterial counterpart: important players in ribosomal function

  2006cited by this paper
• Ribosome Dysfunction Is an Early Event in Alzheimer's Disease

  2005influential reference
• Evaluation of the Nucleolar Organizer Regions in Alzheimer’s Disease

  2005cited by this paper
• Tau protein binds single‐stranded DNA sequence specifically – the proof obtained in vitro with non‐equilibrium capillary electrophoresis of equilibrium mixtures

  2005cited by this paper
• Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly

  2005cited by this paper
• The unfolded protein response is activated in Alzheimer’s disease

  2005cited by this paper
• Protein NPM3 Interacts with the Multifunctional Nucleolar Protein B23/Nucleophosmin and Inhibits Ribosome Biogenesis*

  2005cited by this paper
• Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron*

  2005cited by this paper
• The structure and function of Xenopus NO38-core, a histone chaperone in the nucleolus.

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Ribosome biogenesis: of knobs and RNA processing.

  2004cited by this paper
• Neuronal tau induces DNA conformational changes observed by atomic force microscopy

  2004cited by this paper
• Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.

  2004cited by this paper
• Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain

  2004cited by this paper
• Hippocampal neurons in pre-clinical Alzheimer's disease.

  2004influential reference
• The roles of ribosomal proteins in the structure assembly, and evolution of the large ribosomal subunit.

  2004cited by this paper
• Tau could protect DNA double helix structure.

  2003cited by this paper
• The molecular mechanics of eukaryotic translation.

  2003cited by this paper
• Microtubule associated protein tau binds to double-stranded but not single-stranded DNA

  2003cited by this paper
• Elongation factors in protein biosynthesis.

  2003cited by this paper
• Ribosome assembly in eukaryotes.

  2003cited by this paper
• The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease

  2003cited by this paper
• Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies.

  2003cited by this paper
• Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt–Jakob's disease

  2002cited by this paper
• Analysis by systematic deletion of amino acids of the action of the ribotoxin restrictocin.

  2002cited by this paper
• MinireviewStructure and Function of the Eukaryotic Ribosome : The Next Frontier

  2002cited by this paper
• The tetracycline resistance protein Tet(○) perturbs the conformation of the ribosomal decoding centre

  2002cited by this paper
• Protein synthesis at atomic resolution: mechanistics of translation in the light of highly resolved structures for the ribosome.

  2002cited by this paper
• Phosphorylation of eukaryotic initiation factor-2&agr; (eIF2&agr;) is associated with neuronal degeneration in Alzheimer's disease

  2002cited by this paper
• Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone

  2001cited by this paper
• Quantitative evaluation of the rRNA in Alzheimer's disease.

  2000cited by this paper
• Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau

  2000cited by this paper
• Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

  1999cited by this paper
• Temporal Sequence of Alzheimer’s Disease-Related Pathology

  1999cited by this paper
• Structure and functions of nucleolin.

  1999cited by this paper
• Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells.

  1999cited by this paper
• Neurodegenerative and age-related changes in structure and function of cerebral cortex

  1999cited by this paper
• Nucleolin: a multifunctional major nucleolar phosphoprotein.

  1998cited by this paper
• Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease.

  1998cited by this paper
• Synaptic loss reflected by secretoneurin‐like immunoreactivity in the human hippocampus in Alzheimer's disease

  1998cited by this paper
• Nucleolar localization of the microtubule-associated protein tau in neuroblastomas using sense and anti-sense transfection strategies.

  1997cited by this paper
• Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

  1997cited by this paper
• Tau as a nucleolar protein in human nonneural cells in vitro and in vivo

  1996cited by this paper
• Interaction of nucleolar protein B23 with peptides related to nuclear localization signals.

  1995cited by this paper
• Presence of tau in isolated nuclei from human brain.

  1995cited by this paper
• Localization and in situ phosphorylation state of nuclear tau.

  1995cited by this paper
• The nucleic acid binding activity of nucleolar protein B23.1 resides in its carboxyl-terminal end.

  1994cited by this paper
• Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques

  1994cited by this paper

• Unveiling ribosomal dysfunction and impaired signaling pathways in the cortical region of 5xFAD mice.

  2026cites this paper
• Reference gene variability across age and sex in 5XFAD mice highlights normalization challenges in Alzheimer’s models

  2026cites this paper
• Frameshift variants in the UBTF gene are associated with neurodevelopmental disorders.

  2026cites this paper
• Translational Changes upon Aging and Dietary Restriction in Progeroid DNA-Repair-Deficient Mice

  2026cites this paper
• Fibrillarin: bridging ribosome biogenesis and apoptosis in cellular stress and disease

  2026cites this paper
• Loss of AT8 Nuclear Tau as a Marker of Neuronal Ageing and Alzheimer’s Disease Progression

  2025cites this paper
• Formaldehyde Exposure Induces Systemic Epigenetic Alterations in Histone Methylation and Acetylation.

  2025cites this paper
• Early Dysregulation of RNA Splicing and Translation Processes Are Key Markers from Mild Cognitive Impairment to Alzheimer’s Disease: An In Silico Transcriptomic Analysis

  2025cites this paper
• Nicotinamide N-methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions.

  2025cites this paper
• Organelle abnormalities in Alzheimer's disease.

  2025cites this paper
• Tau oligomer heterogeneity and associated protein profile in slowly versus rapidly progressive Alzheimer’s disease

  2025cites this paper
• Molecular and structural remodeling of stress granules in slowly and rapidly progressive Alzheimer’s disease

  2025cites this paper
• Tau mediates the reshaping of the transcriptional landscape toward intermediate Alzheimer’s disease stages

  2025cites this paper
• In silico profiling of neem limonoids and gut microbiome metabolites for Alzheimer’s therapeutics: targeted inhibition of BACE1 and elucidation of intricate molecular crosstalk with tau oligomers, and bacterial gingipains

  2025cites this paper
• Formaldehyde Exposure Induces Systemic Epigenetic Alterations in Histone Methylation and Acetylation

  2025cites this paper
• Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function

  2025cites this paper
• Phosphorylated-tau associates with HSV-1 chromatin and correlates with nuclear speckles decondensation in low-density host chromatin regions

  2025cites this paper
• Developmental deletion of amyloid precursor protein precludes transcriptional and proteomic responses to brain injury

  2025cites this paper
• Early neuronal reprogramming and cell cycle reentry shape Alzheimer’s disease progression

  2025cites this paper
• SERBP1 interacts with PARP1 and is present in PARylation-dependent protein complexes regulating splicing, cell division, and ribosome biogenesis

  2025cites this paper
• Mutant MAPT Induces rDNA Transcriptional Hyperactivation and Nucleolar Stress in Cellular Models

  2025cites this paper
• Indole and Coumarin Derivatives Targeting EEF2K in Aβ Folding Reporter Cells

  2025cites this paper
• Exploring toxicity and mechanisms of DDTs in Alzheimer's disease through network toxicology and molecular docking insights

  2025cites this paper
• Epigenetics in Neurodegenerative Diseases.

  2025cites this paper
• Label‐Free Proteomic Profiling of the dvls2 (CL2006) Caenorhabditis elegans Alzheimer's Disease (AD) Model Reveals Conserved Molecular Signatures Shared With the Human AD Brain

  2025cites this paper
• Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease

  2024cites this paper
• Meta‐Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross‐Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross‐Study Heterogeneity

  2024cites this paper
• Targeted downregulation of insulin signaling restricts human tau pathogenesis by reinstating the aberrant heterochromatin loss and mTOR/4EBP/S6K pathway in Drosophila.

  2024cites this paper
• Ribosomal DNA and Neurological Disorders.

  2024cites this paper
• DEAD Box Helicase 24 Is Increased in the Brain in Alzheimer’s Disease and AppN-LF Mice and Influences Presymptomatic Pathology

  2024cites this paper
• Distinct calcium sources regulate temporal profiles of NMDAR and mGluR-mediated protein synthesis

  2024cites this paper
• Decoding the molecular script of 2′-O-ribomethylation: Implications across CNS disorders

  2024cites this paper
• An Overview of UBTF Neuroregression Syndrome

  2024cites this paper
• Proteomic Analysis of a Rat Streptozotocin Model Shows Dysregulated Biological Pathways Implicated in Alzheimer’s Disease

  2024cites this paper
• Genetic Insights and Molecular Pathways in Alzheimer's Disease: Unveiling the Complexity of Neurodegeneration

  2024cites this paper
• Exhaustive exercise decreases tau phosphorylation and modifies biological processes associated with the protein translation and electron transport chain in P301L tau transgenic mice.

  2024cites this paper
• Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease

  2024cites this paper
• Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease

  2024cites this paper
• Pancreatic β cell-secreted factor FGF23 attenuates Alzheimer's disease-related amyloid β-induced neuronal death

  2024cites this paper
• Single-cell atlas of transcriptomic vulnerability across multiple neurodegenerative and neuropsychiatric diseases

  2024cites this paper
• Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF ) reveals sex-dependent changes in microglial EV proteome in response to Aβ pathology.

  2024cites this paper
• MAD—microbial (origin of) Alzheimer’s disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems

  2024cites this paper
• DNA Damage and Chromatin Rearrangement Work Together to Promote Neurodegeneration

  2024cites this paper
• Phosphorylation regulates tau’s phase separation behavior and interactions with chromatin

  2024influential citation
• Tau alters global gene expression affecting chromatin in the early stages of Alzheimer’s disease

  2023cites this paper
• Music compensates for altered gene expression in age-related cognitive disorders

  2023cites this paper
• Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

  2023cites this paper
• BANF1 promotes glutamate-induced apoptosis of HT-22 hippocampal neurons

  2023cites this paper
• Nuclear face of Tau: an inside player in neurodegeneration

  2023cites this paper
• Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies

  2023cites this paper
• Tuning gene expression to music: the compensatory effect of music on age-related cognitive disorders

  2023cites this paper
• Role of primary aging hallmarks in Alzheimer´s disease

  2023influential citation
• Identification of key lipid metabolism-related genes in Alzheimer’s disease

  2023cites this paper
• A Continuous Extension of Gene Set Enrichment Analysis using the Likelihood Ratio Test Statistics Identifies VEGF as a Candidate Pathway for Alzheimer’s disease

  2023cites this paper
• Cell Cycle Reactivation, at the Start of Neurodegeneration, Induced by Forskolin and Aniline in Differentiated Neuroblastoma Cells

  2023cites this paper
• Subcellular proteomics insights into Alzheimer's disease development

  2023cites this paper
• Nuclear Tau as an Early Molecular Marker of Alzheimer’s Disease

  2023cites this paper
• Tau: More than a microtubule‐binding protein in neurons

  2023cites this paper
• Ribosomal Dysfunction Is a Common Pathomechanism in Different Forms of Trichothiodystrophy

  2023cites this paper
• Nuclear Tau as an Early Molecular Marker ofAlzheimer’s Disease "2279

  2023cites this paper
• Selective neuronal vulnerability to deficits in RNA processing.

  2023cites this paper
• Transcriptome analysis reveals the neuroprotective effect of Dlg4 against fastigial nucleus stimulation-induced ischemia/reperfusion injury in rats

  2023cites this paper
• Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration

  2023cites this paper
• Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

  2023cites this paper
• Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF) reveals sex-dependent changes in microglial EV proteome in response to Aβ pathology

  2023cites this paper
• Atrophic astrocytes in aged marmosets present tau hyperphosphorylation, RNA oxidation, and DNA fragmentation

  2023cites this paper
• Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats.

  2023cites this paper
• Ribosome biogenesis in disease: new players and therapeutic targets

  2023cites this paper
• GTP energy dependence of endocytosis and autophagy in the aging brain and Alzheimer’s disease

  2023cites this paper
• Phosphorylation regulates tau’s phase separation behavior and interactions with chromatin

  2023cites this paper
• A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer’s Disease via ITGA5

  2023cites this paper
• Ribosomal proteins are blood biomarkers and associated with CD4+ T cell activation in Alzheimer's disease: a study based on machine learning strategies and scRNA-Seq data validation.

  2023cites this paper
• Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination

  2023cites this paper
• In-Depth Proteomic Analysis of De Novo Proteome in a Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Neuronal Nuclear tau and neurodegeneration.

  2022cites this paper
• Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer’s disease

  2022cites this paper
• Silencing of ApoE with Divalent siRNAs Drives Activation of Immune Clearance Pathways and Improves Amyloid Pathology in Mouse Models of Alzheimer’s Disease

  2022cites this paper
• The Caribbean-Hispanic Alzheimer’s disease brain transcriptome reveals ancestry-specific disease mechanisms

  2022cites this paper
• Tibolone Pre-Treatment Ameliorates the Dysregulation of Protein Translation and Transport Generated by Palmitic Acid-Induced Lipotoxicity in Human Astrocytes: A Label-Free MS-Based Proteomics and Network Analysis

  2022cites this paper
• Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbidities

  2022cites this paper
• Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases

  2022cites this paper
• Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice

  2022cites this paper
• Nucleolar Organizer Regions as Transcription-Based Scaffolds of Nucleolar Structure and Function.

  2022cites this paper
• Proteomic alterations in the cerebellum and hippocampus in an Alzheimer's disease mouse model: Alleviating effect of palmatine.

  2022cites this paper
• Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms

  2022cites this paper
• Conserved cell‐type specific signature of resilience to Alzheimer’s disease nominates role for excitatory cortical neurons

  2022cites this paper
• Amyloid beta induces Fmr1‐dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2

  2022cites this paper
• Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia.

  2022cites this paper
• Pathological Nuclear Hallmarks in Dentate Granule Cells of Alzheimer’s Patients: A Biphasic Regulation of Neurogenesis

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• H3K9 Methyltransferases Suv39h1 and Suv39h2 Control the Differentiation of Neural Progenitor Cells in the Adult Hippocampus

  2022cites this paper
• Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice

  2022cites this paper
• Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery

  2022cites this paper
• HP1 proteins regulate nucleolar structure and function by secluding pericentromeric constitutive heterochromatin

  2022cites this paper
• Epigenetic Changes and Chromatin Reorganization in Brain Function: Lessons from Fear Memory Ensemble and Alzheimer’s Disease

  2022cites this paper
• Genome-wide CRISPRi screening reveals regulators of Alzheimer’s tau pathology shared between exosomal and vesicle-free tau seeds

  2022cites this paper
• CRISPRi screening reveals regulators of tau pathology shared between exosomal and vesicle-free tau

  2022cites this paper
• Protein products of nonstop mRNA disrupt nucleolar homeostasis

  2021cites this paper
• FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game

  2021cites this paper
• The Childhood-Onset Neurodegeneration with Cerebellar Atrophy (CONDCA) Disease Caused by AGTPBP1 Gene Mutations: The Purkinje Cell Degeneration Mouse as an Animal Model for the Study of this Human Disease

  2021cites this paper